Loading...

Aging US Population And Digital Channels Will Expand Markets

Published
03 Sep 24
Updated
11 Jun 26
Views
82
11 Jun
US$50.36
AnalystConsensusTarget's Fair Value
US$49.50
1.7% overvalued intrinsic discount
Loading
1Y
36.6%
7D
5.1%

Author's Valuation

US$49.51.7% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 11 Jun 26

Fair value Increased 2.59%

CNO: Highs, Buybacks And Dividend Growth Will Support A Measured Outlook

Analysts have adjusted their price target on CNO Financial Group from $48.25 to $49.50, citing updated assumptions related to discount rates, fair value estimates, and future P/E expectations.

What's in the News

  • CNO Financial Group stock set an all time high of US$48.66 after reporting first quarter 2026 financial results that were stronger than analyst expectations for both earnings per share and revenue. Source: CNO Financial Group Inc stock hits all-time high at 48.66 USD.
  • Evercore ISI upgraded CNO Financial Group from Underperform to In Line and set a price target of US$48. The firm cited positive trends in long term care claims, a shift toward shorter duration policies with 65% of long term care policies at one year or less, and the relative performance of the long term care portfolio compared with peers. Source: Evercore ISI Upgrades CNO Financial to In Line on Strong LTC Performance and Q1 Results.
  • CNO Financial Group reported first quarter 2026 revenue growth of 5.3% year over year and earnings per share above analyst expectations. The company also reported a shortfall relative to book value per share estimates, with management describing this as a solid start to 2026. Source: Evercore ISI Upgrades CNO Financial to In Line on Strong LTC Performance and Q1 Results.
  • The stock reached a new 52 week high after reporting earnings per share of US$1.29 on April 30, 2026, compared with a consensus estimate of US$0.91. It currently holds a Zacks Rank #2 (Buy) with an A grade Value score. Source: CNO Financial Group Hits 52-Week High on Strong Earnings and Positive Outlook.
  • The Board of Directors approved a US$0.01 per share increase in the quarterly dividend to US$0.18 per share, described as the 14th consecutive annual dividend increase. The dividend is payable on June 24, 2026, to shareholders of record on June 10, 2026. The company also reported repurchasing 1,400,000 shares for US$60 million in the first quarter of 2026 under its long running buyback program. Source: Company key developments.

Valuation Changes

  • Fair Value: raised slightly from US$48.25 to US$49.50, a move of about 2.6%.
  • Discount Rate: reduced modestly from 7.68% to 7.57%, which can lift calculated fair value by increasing the weight on future cash flows.
  • Revenue Growth: kept essentially unchanged, with the modeled revenue growth rate still showing a decline of about 0.79%.
  • Net Profit Margin: held steady at roughly 10.96%, indicating no material shift in expected profitability in the model.
  • Future P/E: nudged higher from 10.35x to 10.59x, signaling a slightly higher multiple being applied to expected earnings.
1 viewusers have viewed this narrative update

Key Takeaways

  • Growing annuity and life/health sales, alongside expanding digital channels, support revenue gains and margin improvement through lower acquisition costs and scalability.
  • Investments in technology and diversified fee-based products are enhancing productivity, stabilizing earnings, and reducing exposure to margin and regulatory risks.
  • Shifts in interest rates, competition, digital disruption, regulatory changes, and volatile long-term care claims pose ongoing risks to profitability, growth, and margin stability.

Catalysts

About CNO Financial Group
    Through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, insurance products, and financial services for middle-income pre-retiree and retired Americans in the United States.
What are the underlying business or industry changes driving this perspective?
  • Accelerating growth in annuity and life/health policy sales, particularly driven by a rapidly aging U.S. population (11,000 Americans turning 65 each day) and increased focus on retirement income solutions, is expanding CNO's addressable market and supporting consistent, repeatable revenue gains.
  • Strong momentum in digital and web-based direct-to-consumer channels-evidenced by 39% year-over-year growth and over 30% of D2C leads now from digital sources-is reducing customer acquisition costs and is expected to drive further margin expansion and scalability.
  • Sustained investments in technology (e.g., automation, accelerated underwriting, digital CRM platforms) are improving agent productivity and operating leverage, supporting downward trends in the expense ratio and creating a pathway for higher net margins over the next several years.
  • Expansion of fee-based and asset-light products (such as advisory/brokerage assets up 27% YoY) is diversifying revenue streams, mitigating margin compression risk, and positioning CNO to benefit from increased consumer financial awareness and demand for holistic retirement solutions.
  • Resilience in the supplemental health and Medicare business, supported by annual repricing mechanisms for Medicare Supplement and the ability to promptly respond to claims trends, provides earnings stability and reduces regulatory or underwriting risks, helping protect overall earnings and future profitability.
CNO Financial Group Earnings and Revenue Growth

CNO Financial Group Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming CNO Financial Group's revenue will remain fairly flat over the next 3 years.
  • Analysts assume that profit margins will increase from 5.4% today to 11.0% in 3 years time.
  • Analysts expect earnings to reach $483.0 million (and earnings per share of $5.73) by about June 2029, up from $245.5 million today.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 10.6x on those 2029 earnings, down from 19.0x today. This future PE is lower than the current PE for the US Insurance industry at 11.2x.
  • Analysts expect the number of shares outstanding to decline by 3.7% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.57%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Prolonged low interest rates or periods of declining interest rates could compress investment income and yields on CNO's sizable fixed income and annuity portfolios, negatively impacting net investment margins and overall profitability.
  • Intensifying competition in the annuities market, particularly from private equity and alternative asset managers seeking to capture share in middle-market retirement and insurance solutions, could pressure CNO's pricing power and slow top-line revenue growth.
  • Shifts in consumer preferences toward digital, direct-to-consumer insurance solutions may outpace CNO's current digital transformation efforts, potentially leading to higher acquisition costs and margin compression if legacy distribution models do not keep up.
  • Heightened regulatory and compliance scrutiny, especially with evolving Medicare/healthcare policy, may increase operational costs and create business model uncertainty-particularly given CNO's concentration in senior and middle-income markets that depend on government programs, risking future revenue stability.
  • Long-term care (LTC) claims experience is currently favorable, but any normalization or deterioration to pre-pandemic levels would increase claim payouts, potentially reducing insurance product margins and earnings predictability over the long term.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $49.5 for CNO Financial Group based on their expectations of its future earnings growth, profit margins and other risk factors.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $4.4 billion, earnings will come to $483.0 million, and it would be trading on a PE ratio of 10.6x, assuming you use a discount rate of 7.6%.
  • Given the current share price of $49.97, the analyst price target of $49.5 is 0.9% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on CNO Financial Group?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives